United States Federal Circuit
Bayer Schering Pharma AG v. Barr Laboratories, Inc., 08-1282
In a patent infringement action involving oral contraceptives, district court judgment is affirmed where plaintiff's patent is invalid due to obviousness as it would have been obvious to a person having ordinary skill in pharmaceutical formulation to try a normal pill in formulating drospirenone as an oral contraceptive.
Appellate Information
- Decided 08/05/2009
- Published 08/05/2009
Judges
Court
- United States Federal Circuit